CORCEPT THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Corcept Therapeutics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Corcept Therapeutics Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $5.68M, a 2319% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $5.68M +$5.45M +2319% Jun 30, 2024 10-Q 2024-07-29
Q1 2024 $61K -$514K -89.4% Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $120K -$1.02M -89.5% Dec 31, 2023 10-Q 2024-07-29
Q3 2023 $178K -$1.53M -89.6% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $235K -$2.03M -89.6% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $575K -$2.23M -79.5% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $1.14M +$629K +122% Dec 31, 2022 10-K 2024-02-15
Q3 2022 $1.71M +$685K +67% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $2.26M +$740K +48.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $2.8M +$780K +38.6% Mar 31, 2022 10-Q 2022-11-03
Q4 2021 $514K -$2M -79.5% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $1.02M -$1.97M -65.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 $1.52M -$1.95M -56.1% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $2.02M -$1.06M -34.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $2.51M -$937K -27.2% Dec 31, 2020 10-K 2022-02-15
Q3 2020 $2.99M +$2.25M +303% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $3.47M +$2.37M +214% Jun 30, 2020 10-Q 2020-08-04
Q1 2020 $3.08M +$1.62M +110% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 $3.45M +$646K +23.1% Dec 31, 2019 10-K 2021-02-23
Q3 2019 $742K Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $1.11M Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.47M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $2.8M Jan 31, 2019 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.